Managing tissue viability issues in patients with cancer approaching the end of life
Intended for healthcare professionals
Evidence & Practice Previous     Next

Managing tissue viability issues in patients with cancer approaching the end of life

Kenneth Robert Ripley Practice educator, School of Health and Social Care, University of Lincoln, Lincoln, England
Mark Collier Nurse consultant – tissue viability, Pilgrim Hospital, United Lincolnshire Hospitals NHS Trust, Boston, England

This article provides an overview of tissue viability issues related to the care of patients with cancer who are approaching the end of life. Altered physiology as a result of various factors is identified, including nutrition, medication and radiotherapy. The article also discusses the presentation and treatment of cutaneous radiation injury, malignant wounds, pressure ulcers and Skin Changes At Life's End (SCALE – an acronym used to describe a set of clinical phenomena associated with changes to the skin of patients approaching the end of life), and makes recommendations for practice.

Nursing Standard. 31, 25, 54-61. doi: 10.7748/ns.2017.e10621


Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Conflict of interest

None declared

Received: 25 July 2016

Accepted: 08 December 2016

Want to read more?

Already subscribed? Log in


Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now